Parker Waichman Alonso LLP News http://www.yourlawyer.com/resources/rss Wed, 07 Jan 2009 04:55:49 -0800 pixel-app en Mississippi River Oil Spill Class Action Lawsuit http://www.yourlawyer.com/articles/read/14837 Mon, 28 Jul 2008 00:00:00 -0700 http://www.yourlawyer.com/articles/read/14837  

The Mississippi River oil spill occurred at about 1:30 a.m., when a 600-foot tanker and a barge loaded with fuel collided.  The barge split in half, spilling more than 419,000 gallons of tar-like oil into the river. The barge’s owner, American Commercial Lines, immediately took responsibility for the oil spill. The  barge was being towed by the tugboat the Mel Oliver. Last week, the US Coast Guard determined that no one on the Mel Oliver had the proper licensing for piloting a tugboat.

 

The Mississippi River oil spill class action lawsuit was filed by New Orleans residents Stephen Marshall Gabarick and Bernard Attridge.   The lawsuit claims that following the oil spill, prevailing winds exposed residents and inhabitants of New Orleans to toxic fumes that were spread from the collision site to the French Quarter and Uptown.  The lawsuit also alleges that heavy oil has caused serious environmental damage to the river, threatened sensitive wetlands, and forced closure of several communities' water intakes to prevent contamination of drinking water supplies.

 

Because the oil spill has resulted in the closure of an 80-mile stretch of the Mississippi River, the plaintiffs allege that the incident has caused and will continue to cause loss of income to individuals and businesses that are being prevented from using the waterway.

 

Defendants named by the Mississippi River oil spill class action lawsuit include Laurin Maritime, the Houston firm that operates the Liberian-flagged tanker MV Tintomara; that ship's owner, Gibraltar-based Whitefin Shipping Co. Limited; American Commercial Lines Inc., the Indiana company that owns the barge; DRD Towing, the Harvey company that owns the tugboat Mel Oliver; and the New Orleans-Baton Rouge Steamship Pilots Association, one of whose members was in command of the Tintomara at the time of the collision.

 

Under the Oil Pollution Act of 1990 (OPA), individuals and entities impacted by oil spills are entitled to compensation for property loss, loss of income and other damages caused by the incident.  Parties deemed responsible for an oil spill are liable for such losses.

 

If you or a loved one suffered economic or other damages as a result of the Mississippi River oil spill, you have valuable legal rights.  Please fill out our online form, or call 1-800-LAW-INFO (1-800-529-4636) to discuss your case with a qualified Mississippi River oil spill lawyer.

 

]]>
Class Action Status Requested To Benefit All Persons Who Reside in the State of Florida who Purchased, Consumed, Ingested or Used Recalled Baxter Heparin http://www.yourlawyer.com/articles/read/14107 Thu, 27 Mar 2008 00:00:00 -0700 http://www.yourlawyer.com/articles/read/14107 Parker Waichman Alonso LLP Files Suit Against Baxter Healthcare Corporation and Baxter International, Inc. on Behalf of a Man Injured by Recalled Heparin

Class Action Status Requested To Benefit All Persons Who Reside in the State of Florida who Purchased, Consumed, Ingested or Used Recalled Baxter Heparin

Parker Waichman Alonso LLP and Becnel Law Firm, LLC announce that it has filed suit on behalf of a man who suffered an adverse reaction as a result of contaminated Heparin manufactured and distributed by Baxter Healthcare Corporation and Baxter International, Inc. Since November 2007, Baxter Heparin has been linked to serious and sometimes life-threatening allergic reactions in some patients.  Serious reactions to the drug include difficulty breathing, nausea, vomiting, excessive sweating and rapidly falling blood pressure that can lead to life threatening shock.  The lawsuit was filed in the US District Court for the Southern District of Florida (Docket Number:  # 9:08-cv-80311-KAM).

David D'Amico, a resident of Florida, was administered Heparin distributed by Baxter International and Baxter Healthcare Corporation.  D'Amico alleges that he suffered personal injuries as a result of the contaminated Heparin and also incurred substantial damages including, among other things, medical and hospital expenses, loss of income, and pain and suffering due to the negligence of Baxter International, Inc. and Baxter Healthcare Corporation.

Heparin is a vital drug used to prevent blood clots in dialysis patients and others.  Sales of Baxter Heparin constitute roughly 50% of the market share in the United States.  As early as November 2007, reports of adverse reactions to Baxter Heparin from 19 dialysis clinics in more than 12 states have been reported.   According to the Food & Drug Administration (FDA), there have been 350 reports of adverse reactions to Baxter Heparin since December 2007, in contrast to 100 such reports the agency received in all of 2007. At least four of the reports since November, 2007 involved fatalities.

In January 2008, Baxter International, Inc. and Baxter Healthcare Corporation announced a recall of 9 lots of Heparin Sodium 1000 unit/mL vials for injection.  In February, the FDA warned healthcare practitioners not to use Baxter Heparin products, and on February 29, Baxter expanded the Heparin recall to include all of its Heparin products sold in the United States.  Since the Baxter Heparin recall, the FDA has confirmed that the active ingredient for Heparin that Baxter sourced from China had been contaminated with a chemical called over-sulfated chondroitin sulfate, a substance derived from animal cartilage.  The FDA said that the chondroitin sulfate had been molecularly altered to mimic the blood-clotting properties of Heparin.

If you or a loved one suffered a serious injury after being administered Heparin manufactured by Baxter International, Inc. and Baxter Healthcare Corporation, please contact our office by visiting www.yourlawyer.com.  Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

About Parker Waichman Alonso LLP

Parker Waichman Alonso LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide.  The firm has offices in Florida, New York and New Jersey.  Parker Waichman Alonso LLP has assisted thousands of clients in receiving fair compensation for injuries resulting from defective drugs, tainted foods, medications and medical devices.   

About Becnel Law Firm LLC  

Becnel Law Firm LLC is a full service law firm representing clients both locally and nationally.  Becnel Law Firm, LLC has been in existence for over 30 years and is one of the largest personal injury firms in the New Orleans area. 

 

CONTACT:  Parker Waichman Alonso LLP          

                        Fred R. Rosenthal, Managing Attorney
                        (800) LAW-INFO
                        (800) 529-4636
                        info@yourlawyer.com
                        www.yourlawyer.com

]]>
Slain child's father sues Nassau for negligence http://www.yourlawyer.com/articles/read/13961 Fri, 29 Feb 2008 00:00:00 -0800 http://www.yourlawyer.com/articles/read/13961 The father of Jewell Ward, one of the three children allegedly killed in their New Cassel home Sunday by their mother, is suing Nassau County, claiming its "negligence, carelessness and recklessness" led to a failure to prevent the tragedy.

Rickey Ward, of Hempstead, who is being represented by the Mineola firm of Parker Waichman Alonso, filed a notice of claim that he will seek $50 million. The notice names Nassau County, its Child Protective Services, and its Department of Social Services as the defendants.

Nassau County Attorney Lorna Goodman said she could not comment on pending litigation.

Attorney Andres Alonso said the suit's initial goal is to require Nassau investigators to preserve, and eventually make available, all evidence in the death of Ward's 6-year-old daughter, as well as the girl's two slain younger brothers. The father of the two younger children, Michael Demesyeux, 5, and Innocent Demesyeux, 18 months, is also named Innocent Demesyeux.

Ward's attorneys contend that the county bore some responsibility in the deaths by not sharing information among agencies regarding Brewer's criminal and mental health history, and by not sending a CPS worker to the home on Saturday after receiving calls from Innocent Demesyeux claiming that Brewer was using drugs and threatening to harm the children.

Ward's attorneys said that had the county agencies done their jobs, the children would have been removed from the home and alive today.

"In doing nothing, they sacrificed these children," Alonso said. "This woman was a ticking time bomb, and they ignored her."

 

]]>
Medtronic Sprint Fidelis Defibrillator Lead Lawsuit Claims Center Opens to Aid Victims - Free Case Review by our Medtronic Lead Injury Lawyers and Attorneys for a Potential Lawsuit. http://www.yourlawyer.com/articles/read/13250 Wed, 24 Oct 2007 00:00:00 -0700 http://www.yourlawyer.com/articles/read/13250

Keywords: Lawsuit | Medtronic | Lawyer | Lead | Fidelis | Attorney | Recall | Injury

Parker Waichman Alonso LLP Announces Opening of Dedicated Claims Center To Evaluate Numerous Possible Lawsuits Related to Defective Sprint Fidelis Leads Used With Medtronic Implantable Defibrillators. 

(New York) October 24, 2007 – The defective Medtronic Sprint Fidelis Defibrillator Leads were implanted into hundreds of thousands of people, leaving all of them at risk for serious injury if a Sprint Fidelis Lead fractures.  As a result of this, Parker Waichman Alonso LLP has opened a dedicated Claims Center within their office to review the potential lawsuits of people who were implanted with defective Sprint Fidelis Leads used with Medtronic defibrillators.   Medtronic suspended sales and recalled all unused Sprint Fidelis Leads on October 15, 2007 after receiving reports of at least 5 fatalities linked to lead fractures. Parker Waichman Alonso LLP recently filed a lawsuit on behalf of a man who had to undergo a dangerous and life-threatening surgical procedure after a Sprint Fidelis Lead fractured.  Parker Waichman Alonso LLP is seeking class action status for this lawsuit to represent all persons in the United States who were implanted with defective leads manufactured by Medtronic, Inc.

If you or a loved one received a Sprint Fidelis Lead with a Medtronic implantable defibrillator, please contact our claims center by visiting www.yourlawyer.com.  Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

The Sprint Fidelis Lead is a wire that is used to attach a Medtronic implantable defibrillator to the heart.   The Sprint Fidelis Lead was first introduced by Medtronic in 2004, and has been used with most of the company’s implantable defibrillators since then.  This component is used in cardiac defibrillators -- or complex devices with defibrillation capacity -- and not in conventional pacemakers. Some patients with congestive heart failure use devices that include this defibrillation ability, and those are among the machines that use the Sprint Fidelis Lead.

Medtronic’s Sprint Fidelis Leads have been shown to have a continuing fracture problem.  This defect can cause the defibrillators to deliver a massive and painful electrical shock, or it can cause the device to fail to administer a lifesaving shock when necessary.   Such defects were discussed in an article written by doctors at The Minneapolis Heart Institute, one of the premier heart institutes in the world.   The researchers at the Minneapolis Heart Institute compared data regarding lead failures in both the Sprint Fidelis models and Medtronic’s earlier Sprint Quattro models. The study found the thinner Sprint Fidelis Lead had a higher chance of fracturing than the Sprint Quattro. According to Medtronic’s own estimate, approximately 2.3%, or 4,000 to 5,000 people with a Sprint Fidelis Lead will experience fracture within 30 months of having a defibrillator implanted.  

When a Sprint Fidelis Lead fractures, a patient must undergo a surgical procedure that can tear and scar the heart tissue and veins through which the Sprint Fidelis Lead wire runs.   The surgery to replace a defibrillator lead wire is far riskier than having the device itself replaced.
 
About Parker Waichman Alonso LLP:
Parker Waichman Alonso LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide.  The firm has offices in New York and New Jersey.  Parker Waichman Alonso LLP has assisted thousands of clients in receiving fair compensation for injuries resulting from defective products, drugs and medical devices.

For more information on Parker Waichman Alonso LLP, please visit: www.yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).

CONTACT:    Parker Waichman Alonso LLP
                  David Krangle, Esq.
                  (800) LAW-INFO
                  (800) 529-4636
                  info@yourlawyer.com
                  www.yourlawyer.com

]]>
Parker Waichman Alonso LLP, along with Smith & Nevares, Salas & Co. and Becnel Law Firm, LLC, File Suit against Medtronic Inc., Medtronic Puerto Rico, Inc., and Medtronic Puerto Rico Operations Co. on Behalf of Man Injured by Defective Sprint Fidelis Lead http://www.yourlawyer.com/articles/read/13220 Wed, 17 Oct 2007 00:00:00 -0700 http://www.yourlawyer.com/articles/read/13220 Parker Waichman Alonso LLP, along with Smith & Nevares, Salas & Co. and Becnel Law Firm, LLC, announce that they have filed a lawsuit on behalf of a man who had to undergo a dangerous and life-threatening surgical procedure after a component of his Medtronic implantable defibrillator called a Sprint Fidelis lead fractured.  The victim is bringing this action on his own behalf and as a representative of a class consisting of all persons who reside in the United States and were implanted with a lead manufactured by Medtronic, Inc., except those individuals whose Medtronic lead have malfunctioned.  The suit was filed on behalf of the victim in the United States District Court for the District of Puerto Rico (Docket number: 07-1971).

If you or a loved one believes that you were injured as a result of a Sprint Fidelis lead used with a Medtronic implantable defibrillator, please contact our office by visiting www.yourlawyer.com.  Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

The Sprint Fidelis lead is a wire that is used to attach a Medtronic implantable defibrillator to the heart.   The Sprint Fidelis lead was first introduced by Medtronic in 2004, and has been used with most of the company’s implantable defibrillators since then.  To date, Sprint Fidelis leads have been implanted in 235,000 patients. This component is used in cardiac defibrillators -- or complex devices with defibrillation capacity -- and not in conventional pacemakers. Some patients with congestive heart failure use devices that include this defibrillation ability, and those are among the machines that use the Sprint Fidelis lead.

According to the lawsuit, the victim, a resident of Kentucky, received a cardiac pacemaker/defibrillator combination (an “ICD”).  The ICD was attached to his heart with a Sprint Fidelis lead wire system manufactured by Medtronic on March 25, 2005.  On June 22, 2006, the lead had to be surgically removed in an emergency procedure after it was found to be “frayed” in the nature of a fracture.

Those patients whose Sprint Fidelis lead fractures must undergo a dangerous surgical procedure to have the wire replaced.  The procedure could cause tearing and scarring of the heart and veins through which the Sprint Fidelis lead wire runs.   The surgery to replace a defibrillator lead wire is far riskier than having the device itself replaced.

Defibrillator leads are one of the devices most fragile components Since the Sprint Fidelis lead was introduced to the market in 2004 it has become evident that a significant portion of the leads have potentially fatal defects.  Such defects were discussed in an article written by doctors at The Minneapolis Heart Institute, one of the premier heart institutes in the world, based on a study of the incidence of lead failures in the Sprint Fidelis models compared to the Sprint Quattro models.  Researchers at The Minneapolis Heart Institute found that, between September 2004 and February 2007, 583 patients were implanted with Sprint Fidelis Model 6949 leads and nine patients received other Sprint Fidelis models.  During that time, six patients experienced Sprint Fidelis Model 6949 lead failures.  The failed Sprint Fidelis Model 6949 leads had been implanted by various electrophysiologists, cardiologists and thoracic surgeons.  The average time to failure was fourteen months (based on a range of four to twenty-three months).  Medtronic first notified physicians in March 2007 about the high fracture rate of the Sprint Fidelis lead.   

In October 2007, Medtronic suspended sales of the Sprint Fidelis lead used in its implantable defibrillators after an analysis of the company’s data showed that the lead had a continuing fracture problem.  This defect can cause the defibrillators to deliver a massive and painful electrical shock, or it can cause the device to fail to administer a lifesaving shock when necessary.   According to Medtronic’s own estimate, approximately 2.3%, or 4,000 to 5,000 people with a Sprint Fidelis lead will experience fracture within 30 months of having a defibrillator implanted.   At least 5 patient deaths have been attributed to defective Sprint Fidelis leads.

About Parker Waichman Alonso LLP:
Parker Waichman Alonso LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide.  The firm has offices in New York and New Jersey.  Parker Waichman Alonso LLP has assisted thousands of clients in receiving fair compensation for injuries resulting from defective products, medications and medical devices.
For more information on Parker Waichman Alonso LLP, please visit: www.yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).

CONTACT:    Parker Waichman Alonso LLP
                  David Krangle, Esq.
                  (800) LAW-INFO
                  (800) 529-4636
                  info@yourlawyer.com
                  www.yourlawyer.com

 

 

]]>
Andres F. Alonso of Parker Waichman Alonso LLP Quoted in The Star Ledger http://www.yourlawyer.com/articles/read/13128 Wed, 19 Sep 2007 00:00:00 -0700 http://www.yourlawyer.com/articles/read/13128 J&J faces thousands of Ortho lawsuits

The numbers keep adding up for the Ortho Evra birth-control patch.

Not sales -- those are down sharply -- but the docket of product liability cases filed against Johnson & Johnson, the maker of the one-of-a-kind contraceptive.

In its latest update last month, J&J said more than 2,400 Ortho Evra lawsuits are queued up in state and federal courts. Some 400 are New Jersey cases that have been consolidated in the Middlesex County Courthouse in New Brunswick, just a few blocks from the health-care conglomerate's headquarters.

Most of the lawsuits have a common theme: J&J allegedly knew the skin patch had greater safety risks than birth-control pills, particularly in the incidence of harmful blood clots that could develop in women's legs and lungs. But it chose to aggressively market the contraceptive in ads featuring supermodel Naomi Campbell and others, and soft-pedaled the dangers.

J&J denies the claims, and says Ortho Evra is a "safe and needed" contraceptive if used according to its label.

But the company's defense has a complication: Two former executives have said they raised red flags about the patch's safety but were ignored.

One is Joel Lippman, a medical officer whose claims about problems with Ortho Evra and other products were first made public in a state whistleblower suit last year. The other is a J&J vice president who decided to resign from a job overseeing the "benefit risk and safety evaluation" of reproductive products -- including the patch -- after being unable to properly "exercise this responsibility," according to a recently unsealed document in the New Jersey litigation.

The latter filing is an October 2005 letter addressed to J&J Chief Executive William Weldon by the executive, whose name and exact job title were redacted by the court. The officer said he or she had left the company the previous month in part because Ortho Evra's risks had been downplayed, despite "compelling evidence" to the contrary.

"My discomfort on the issues mentioned above was and is still shared by many of my former colleagues, and several of them asked me to be more open on the reasons for my resignation," the person wrote.

J&J said the former employee, who tracked adverse reactions to the patch after it was on the market, vouched for its safety to both the company and the Food and Drug Administration while working there.

More than 4 million women used Ortho Evra after it was approved for sale in the United States in 2001. It's biggest selling point is convenience -- slap the patch on for a week, and you're set. But having a hormonal contraceptive delivered through the skin turns out to be a different proposition than digesting it in a daily pill.

In 2005, the FDA and J&J agreed to make a change in Ortho Evra's label that said users of the patch could be exposed to 60 percent more estrogen than women who used the pill.

Oral contraceptives have been linked to some risk of harmful side effects, such as deep-vein thrombosis or pulmonary embolism, a potentially fatal condition in which clots form in the body and make their way to the lungs. To the women suing J&J, greater estrogen exposure from the patch means greater risk of death or injury.

"They should have warned about that, and they didn't," said Andres Alonso, a partner with Parker & Waichman, which represents more than 600 Ortho Evra plaintiffs.

Another plaintiff attorney, Gary Douglas, said Johnson & Johnson had data showing the different rates of exposure before the drug was approved. Douglas is scheduled to try the first Ortho Evra case, a wrongful death suit brought by the estate of 18-year-old college student Zakiya Kennedy, this fall in New York.

"Johnson & Johnson not only knew their product delivered more estrogen than the pill, but deliberately manipulated the numbers and results of the clinical trials to reflect that it delivered the same amount as the pill," Douglas said.

Lippman has already been deposed in the New Jersey litigation, according to his lawyer. The executive, who helped oversee clinical trials for the patch, said he raised questions about the "dangerously high levels of estrogen" emitted by Ortho Evra in the late 1990s but was ignored. J&J has said Lippman's allegations are untrue, and that he was fired from another post in 2006 for conduct unrelated to his safety claims.

An FDA medical reviewer cited the potential for clot-related problems with Ortho Evra in 2001, and said post-market studies would be necessary. But the patch was ultimately approved by the agency, and the revised label says "it is not known" if the patch's different profile of estrogen exposure leads to more serious health problems than the pill.

Preliminary data from two, large J&J-funded studies last year were a mixed bag. One showed a twofold increase in events involving clots with Ortho Evra users compared with women who took oral contraceptives. Another showed no difference at all.

Both epidemiological studies are ongoing, and the full results could be critical to the outcome of the litigation.

No trial date is set yet for the New Jersey cases, but jury selection for the Kennedy case is expected to commence on Nov 19. The first federal suit is expected to go on trial in June next year in Cincinnati, Ohio, where U.S. District Court cases have been pooled.

The vice president who wrote Weldon said the company chose to publicize early study data that showed comparable safety results between the patch and the pill, even though J&J was aware of more than 20 deaths that had been tied to Ortho Evra after it hit the market.

"It was decided to quickly try to communicate in priority on these partial and incomplete results, despite compelling evidence that the estrogenic exposure was unusually high compared to an oral product, and that the reporting rate of fatalities and of various thromoboembloic disorders was out of range for this class of products," the executive wrote in the letter.

Weldon did not respond to the executive, but the head of the former employee's business unit arranged a meeting to discuss the concerns soon afterwards, said Gloria Vanderham, a spokeswoman for Ortho Women's Health & Urology, the J&J unit that sells the birth-control patch.

Saddled with inconclusive results from studies, doctors are prescribing other contraceptives. Peak sales of Ortho Evra were $416 million in 2005, but fell 45 percent last year and were off another 39 percent in the first six months of this year, according to IMS Health. In the past year, the patch has been eclipsed by Organon's NuvaRing and an uptick in oral contraceptives.

Still, Wall Street hasn't taken much notice of the Ortho Evra litigation yet. Investors have bigger concerns about J&J, such as the coming patent expirations of several major drugs and the slump in sales of drug-coated coronary stents, said Les Funtleyder, a health-care analyst with Miller Tabak.

"It's sort of on the radar screen, but it's way, way down," Funtleyder said.

]]>
Goldman Sachs Group, Inc. and Kelso & Company Affiliates Named as Additional Defendants to Kansas Oil Spill Lawsuit http://www.yourlawyer.com/articles/read/12906 Mon, 16 Jul 2007 00:00:00 -0700 http://www.yourlawyer.com/articles/read/12906 Complaint Amended to add additional defendants on behalf of a Coffeyville Resident and Business Owner, Include Entities Principally Owned by Goldman Sachs Group, Inc., Kelso & Company and its Affiliates

Parker Waichman Alonso LLP, Hutton & Hutton Law Firm LLC, Neblett Beard & Arsenault and Becnel Law Firm have been retained by numerous individuals and business owners who have sustained losses as a result of Coffeyville Oil Spill 

Amended Complaint Seeking Class Action Status Filed in Kansas District Court to Benefit All Affected Residents and Businesses 

Parker Waichman Alonso LLP, Hutton & Hutton Law Firm LLC, Neblett, Beard & Arsenault and Becnel Law Firm LLC announce that additional defendants have been added to a class action lawsuit they have filed.  The lawsuit was filed suit on behalf of a man who lost his house and business as a result of the oil that spilled from the Coffeyville Resources refinery.  The suit was initially filed on July 5, 2007 in the United States District Court, District of Kansas as a class action lawsuit and has been assigned to Judge J. Thomas Marten (Docket Number 6:07-CV-1186).  One of the additional defendants include Coffeyville Acquisition, LLC, an entity principally owned by Goldman Sachs Group, Inc., its subsidiary J. Aron & Company, Kelso & Company and/or its affiliates. Other additional defendants include CVR Energy, Inc.;  Coffeyville Group Holdings, LLC;  Coffeyville Refining and Marketing Inc.;  Coffeyville Resources Crude Transportation, LLC; Coffeyville Resources Terminal, LLC; and Coffeyville Resources Pipeline, LLC.

On July 1 and July 2, 2007 more than 71,000 gallons of crude oil spilled from the Coffeyville Resources refinery, far more than the 42,000 gallons that was initially reported. The spill occurred when Coffeyville Resources mistakenly allowed crude oil to be pumped into a storage tank long after it had reached capacity.  It was several hours before the leak was discovered. Due to widespread flooding that was occurring at the time of the oil spill, the crude oil reached and damaged a very large area.  More than 2,500 residents and businesses have been displaced by the oil slick and “toxic soup” that made its way on the Verdigris River.  In excess of 200 properties have already been destroyed by these uncontrolled waterborne poisons.  

Parker Waichman Alonso LLP, Hutton & Hutton Law Firm LLC, Neblett, Beard & Arsenault and Becnel Law Firm LLC urge anyone affected by the Coffeyville Resources refinery oil spill to visit www.oilspillclaims.com for a free case evaluation or call 1-800-LAW-INFO (1-800-529-4636).

The economic effects of oil spills can be devastating and far-reaching. Large companies, sole proprietors, and individuals alike stand to endure major economic losses when oil spills occur. Under the Oil Pollution Act of 1990, the responsible party is liable for the costs associated with the containment or cleanup of the spill and any damages resulting from the spill.

Oil spills cause large scale damage, destruction and death to aquatic environments. The type of oil determines the type of damage. Crude oil is suffocating and has a toxic effect because it is like a heavy tar. Crude oil is difficult to clean and can linger in the environment for many years.   Crude oil causes much damage to birds and mammals; it sticks to their fur or feathers, causing hypothermia by reducing insulation and making them easy prey. It also causes loss of weight due to lack of ability to feed and also causes damage to the digestive systems when the oil is ingested.   Crude oil can destroy food and water supplies, produce toxic fumes, and destroy shorelines and riverbanks. Refined petroleum such as gasoline is generally more toxic but evaporates quickly.  Refined petroleum causes damage not due to stickiness but due to toxicity. Animals become poisoned when they ingest refined petroleum products, and the poison travels up the food chain. Respiratory, immune and adrenal systems are also damaged. Blood and organs are damaged. Breeding is interrupted or halted, or offspring become poisoned and die.

About Parker Waichman Alonso LLP
Parker Waichman Alonso LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide. The firm has offices in New York and New Jersey. Parker Waichman Alonso LLP has represented thousands of clients in receiving fair compensation for injuries resulting from defective products, tainted foods, defective pharmaceuticals and medical devices, toxic spills and medical malpractice.  For more information on Coffeyville Resources refinery oil spill to visit www.oilspillclaims.com

About Hutton & Hutton LLC
Hutton & Hutton represents people who suffer personal injury and/or economic harm. The Firm has obtained verdicts and settlements exceeding $200 million in Kansas, Oklahoma and other states.

About Neblett, Beard & Arsenault LLP
Neblett, Beard & Arsenault has represented injury victims and their families for almost three decades. They represent people who have suffered serious injury and death resulting from offshore and maritime incidents, automobile accidents, dangerous products, medical negligence, workplace accidents, and environmental exposure to dangerous and toxic substances. They also served on the executive committee in the litigation brought as a result of the oil spill at the Murphy Oil refinery during Hurricane Katrina.
 
Becnel Law Firm LLC 
Becnel Law Firm LLC is a full service law firm representing clients both locally and nationally.  Becnel Law Firm, LLC has been in existence for over 30 years and is one of the largest personal injury firms in the New Orleans area.  They were heavily involved in the litigation and resolution of numerous claims brought as a result of the oil spill at the Murphy Oil refinery during Hurricane Katrina.

CONTACT: 

Parker Waichman Alonso LLP
David Krangle, Esq.
1-800-LAW-INFO
1-800-529-4636
dkrangle@yourlawyer.com
www.yourlawyer.com


 

]]>
Parker Waichman Alonso LLP, Hutton & Hutton Law Firm LLC, Neblett, Beard & Arsenault and Becnel Law Firm LLC File Lawsuit Concerning Kansas Oil Spill on behalf of a Coffeyville Resident and Business Owner http://www.yourlawyer.com/articles/read/12891 Fri, 06 Jul 2007 00:00:00 -0700 http://www.yourlawyer.com/articles/read/12891 Class Action Status Requested To Benefit All Affected Residents and Businesses 

Parker Waichman Alonso LLP, Hutton & Hutton Law Firm LLC, Neblett, Beard & Arsenault and Becnel Law Firm LLC  announces that they have filed suit on behalf of a man who lost his house and business as a result of the oil that spilled from the Coffeyville Resources refinery.  The suit was filed on July 5, 2007 in the United States District Court, District of Kansas as a class action lawsuit and has been assigned to Judge J. Thomas Marten (Docket Number 6:07-CV-1186). The defendants named in the complaint include Coffeyville Resources, LLC; Coffeyville Resources Refining & Marketing, LLC; Coffeyville Resources Crude Transportation, LLC; Coffeyville Resources Terminal, LLC; Coffeyville Resources Pipeline, LLC; and Coffeyville Resources Nitrogen Fertilizers, LLC.

On July 1 and July 2, 2007 more than 71,000 gallons of crude oil spilled from the Coffeyville Resources refinery, far more than the 42,000 gallons that was initially reported.  Due to widespread flooding that was occurring at the time of the oil spill, the crude oil reached and damaged a very large area.  More than 2,500 residents and businesses have been displaced by the oil slick and “toxic soup” that made its way on the Verdigris River.  In excess of 200 properties have already been destroyed by these uncontrolled waterborne poisons.   Refinery officials said they are still investigating how the spill occurred.

Parker Waichman Alonso LLP, Hutton & Hutton Law Firm LLC, Neblett, Beard & Arsenault and Becnel Law Firm LLC urge anyone affected by the Coffeyville Resources refinery oil spill to visit www.oilspillclaims.com for a free case evaluation or call 1-800-LAW-INFO (1-800-529-4636).

The economic effects of oil spills can be devastating and far-reaching. Large companies, sole proprietors, and individuals alike stand to endure major economic losses when oil spills occur. Under the Oil Pollution Act of 1990, the responsible party is liable for the costs associated with the containment or cleanup of the spill and any damages resulting from the spill.

Oil spills cause large scale damage, destruction and death to aquatic environments. The type of oil determines the type of damage. Crude oil is suffocating and has a toxic effect because it is like a heavy tar. Refined petroleum such as gasoline is generally more toxic but evaporates quickly. Crude oil causes much damage to birds and mammals; it sticks to their fur or feathers, causing hypothermia by reducing insulation and making them easy prey. It also causes loss of weight due to lack of ability to feed and also causes damage to the digestive systems when the oil is ingested. Refined petroleum causes damage not due to stickiness but due to toxicity. Animals become poisoned when they ingest refined petroleum products, and the poison travels up the food chain. Respiratory, immune and adrenal systems are also damaged. Blood and organs are damaged. Breeding is interrupted or halted, or offspring become poisoned and die.

About Parker Waichman Alonso LLP

Parker Waichman Alonso LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide. The firm has offices in New York and New Jersey. Parker Waichman Alonso LLP has represented thousands of clients in receiving fair compensation for injuries resulting from defective products, tainted foods, defective pharmaceuticals and medical devices, toxic spills and medical malpractice.  For more information on Coffeyville Resources refinery oil spill to visit www.oilspillclaims.com

About Hutton & Hutton LLC

Hutton & Hutton represents people who suffer personal injury and/or economic harm. The Firm has obtained verdicts and settlements exceeding $200 million in Kansas, Oklahoma and other states.

About Neblett, Beard & Arsenault LLP
Neblett, Beard & Arsenault has represented injury victims and their families for almost three decades. They represent people who have suffered serious injury and death resulting from offshore and maritime incidents, automobile accidents, dangerous products, medical negligence, workplace accidents, and environmental exposure to dangerous and toxic substances. They also served on the executive committee in the litigation brought as a result of the oil spill at the Murphy Oil refinery during Hurricane Katrina. 

About Becnel Law Firm LLC  

Becnel Law Firm LLC is a full service law firm representing clients both locally and nationally.  Becnel Law Firm, LLC has been in existence for over 30 years and is one of the largest personal injury firms in the New Orleans area.  They were heavily involved in the litigation and resolution of numerous claims brought as a result of the oil spill at the Murphy Oil refinery during Hurricane Katrina.

CONTACT:  

Parker Waichman Alonso LLP
David Krangle, Esq.
1-800-LAW-INFO
1-800-529-4636
dkrangle@yourlawyer.com
www.yourlawyer.com

]]>
Parker Waichman Alonso LLP Files Suit Against Bausch & Lomb, Inc. on Behalf of Man Diagnosed with Fusarium Keratitis After Using Renu with MoistureLoc http://www.yourlawyer.com/articles/read/12886 Mon, 02 Jul 2007 00:00:00 -0700 http://www.yourlawyer.com/articles/read/12886 Parker Waichman Alonso LLP announces that it has filed suit on behalf of a man diagnosed with Fusarium Keratitis in his right eye after using Renu with MoistureLoc® Contact Lens Solution.  As a result of the infection, the man continues to suffer from a significant loss of vision.  The suit was filed in the Supreme Court of the State of New York, New York County.

If you or a loved one believe that you were injured as a result of using Bausch & Lomb’s ReNu with MoistureLoc® Contact Lens Solution, please contact our office by visiting www.yourlawyer.com.   Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

In October 2005, the injured man, a resident of Georgia, was diagnosed with injuries to his right eye including fungal keratitis, a corneal ulcer, epithelial defect, corneal edema and corneal perforation, all of which required extensive medical treatment.  In November 2005, his right eye tested positive for Fusarium.  As a result of these injuries, the victim now suffers from a significant and permanent loss of vision.

On April 10, 2006, the FDA and the CDC issued public health warnings concerning serious fungal infections associated with contact lens solution use. The CDC stated that it had interviewed 30 patients suspected of having fungal keratitis. Of these 30 patients, 28 wore soft contact lenses and 26 used a Bausch & Lomb ReNu contact lens solution in the month prior to the fungal infection diagnosis. On April 13, 2006, Bausch & Lomb, Inc. recommended that consumers switch to another lens care solution and asked all retailers to remove U.S. manufactured ReNu with MoistureLoc®  from their shelves. On May 2, 2006 the CDC announced that the number of confirmed fungal infections rose to 88 cases.  Just three days later, on May 5, 2006, the CDC revised the number of confirmed cases to 102.

On May 12, 2006, the CDC made another upward revision in the number of confirmed fungal eye infections to 122 cases. On May 15, 2006, the FDA issued a press release stating: “Based on this scientific and epidemiological data suggesting that ReNu with MoistureLoc may increase susceptibility to Fusarium, Bausch & Lomb has decided to permanently remove the ReNu with MoistureLoc product worldwide.’’  The recall followed Bausch & Lomb’s conclusion that the product’s formula may increase the risk of fungal eye infections in certain situations.  Bausch & Lomb, Inc. and the FDA both acknowledged there is a problem in the chemical properties of ReNu with MoistureLoc® after testing confirmed that the solution allows a polymer film to form around the Fusarium fungus preventing the disinfectant in the product from killing the fungus.

Fungal keratitis is a severe infection of the cornea.  Risk factors for infection usually include trauma (generally with plant material), chronic ocular surface diseases, immunodeficiencies, and, rarely, contact lens use.  An estimated 30 million people in the United States wear soft contact lenses; the annual incidence of microbial keratitis is estimated to be 4 - 21 per 10,000 soft contact lens users.  Fungal keratitis is a condition more prevalent in warm climates.  First-line treatment includes topical and oral antifungal medications.  Patients who do not respond to treatment usually require surgical intervention, including corneal transplantation. These infections are not transmitted from person to person.

About Parker Waichman Alonso LLP:  

Parker Waichman Alonso LLP is leading the litigation against Bausch & Lomb, Inc. on behalf of people injured as a result of using ReNu with MoistureLoc® Contact Lens Solution.  Parker Waichman Alonso LLP has also filed a medical monitoring class-action suit against Bausch & Lomb, Inc. seeking compensation for medical evaluations for all people who used ReNu with MoistureLoc. 
Parker Waichman Alonso LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide.  The firm has offices in New York and New Jersey.  Parker Waichman Alonso LLP has assisted thousands of clients in receiving fair compensation for injuries resulting from defective products, medications and medical devices.

For more information on Parker Waichman Alonso LLP, please visit: www.yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).

CONTACT:    Parker Waichman Alonso LLP
                  David Krangle, Esq.
                  (800) LAW-INFO
                  (800) 529-4636
                  info@yourlawyer.com
                  www.yourlawyer.com

 

]]>
Parker Waichman Alonso LLP, are Investigating Numerous Claims for Injuries Sustained as a Result of Gadolinium Based Contrast Agent Injections Used During MRI Scans http://www.yourlawyer.com/articles/read/12862 Wed, 23 May 2007 00:00:00 -0700 http://www.yourlawyer.com/articles/read/12862 Parker Waichman Alonso LLP recently learned that the Federal Drug Administration (FDA) has notified healthcare professionals of the Agency’s request for the addition of boxed warnings and new warnings about the risk of Nephrogenic Systemic Fibrosis (NSF) for all Gadolinium based contrast agents.  The new warnings require highlights, describing the risk for NSF following exposure to Gadolinium in patients with acute or chronic severe renal insufficiency.  The FDA is also requesting the addition of a boxed warning about the risk for NSF.

If you or a loved one believes that you may have sustained Nephrogenic Systemic Fibrosis (NSF), also referred to as Nephrogenic Fibrosining Dermopathy (NFD), please contact our office by visiting www.yourlawyer.com/topics/overview/nsf .  Free case evaluations are also available by calling Parker Waichman Alonso LLP at 1-800-LAW-INFO (1-800-529-4636).

In 2006, researchers found there is a direct connection between the development of Nephrogenic Systemic Fibrosis (NSF) and the use of Gadolinium contrast agents during Magnetic Resonance Imaging (MRI) and Magnetic Resonance Angiography (MRA) for those kidney problems.

An MRI scan is performed to obtain a clear detailed image of a patient’s internal organs and tissues and an MRA is used to obtain a detailed image of a patient’s blood vessels.  During some MRI and MRA scans, a Gadolinium based contrast agent is injected into the patient to highlight blood vessels so they can be distinguished from other nearby tissues.

Symptoms of Nephrogenic Systemic Fibrosis (NSF) are.

  • Burning
  • Itching
  • Swelling
  • Hardening and tightening of the skin
  • Red or dark patches on the skin
  • Yellow spots on the whites of the eyes
  • Stiffness in joints and trouble moving or straightening the arms, hands, legs, feet
  • Pain deep in the hip bones or ribs
  • Muscle weakness
  • Death

About Parker Waichman Alonso LLP:

Parker Waichman Alonso LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide.  The firm has offices in New York and New Jersey.  Parker Waichman Alonso LLP has assisted thousands of clients in receiving fair compensation for injuries resulting from defective products, tainted foods, medications and medical devices.   

]]>